Selected research
Industry Research
Antithrombotic Drugs Industry Research Report 2026
Market perspective
The global Antithrombotic Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antithrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antithrombotic Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antithrombotic Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antithrombotic Drugs include Abbott laboratories, Bristol myers squibb pharma, Bristol-Myers Squibb, Pharmacia, Pliva, Watson laboratories, Zydus pharmaceuticals usa, Pfizer and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antithrombotic Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antithrombotic Drugs Market by Company
Abbott laboratories
Bristol myers squibb pharma
Bristol-Myers Squibb
Pharmacia
Pliva
Watson laboratories
Zydus pharmaceuticals usa
Pfizer
Sandoz
Antithrombotic Drugs Segment by Type
Rivaroxaban
Fondaparinux
Heparin
Apixaban
Edoxaban
Debigatran
Antithrombotic Drugs Segment by Application
Online Retailers
Hospital Pharmacies
Drug Stores
General Pharmacies
Antithrombotic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithrombotic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antithrombotic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithrombotic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antithrombotic Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antithrombotic Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antithrombotic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rivaroxaban
- Fondaparinux
- Heparin
- Apixaban
- Edoxaban
- Debigatran
Applications
- Online Retailers
- Hospital Pharmacies
- Drug Stores
- General Pharmacies
Companies covered
- Abbott laboratories
- Bristol myers squibb pharma
- Bristol-Myers Squibb
- Pharmacia
- Pliva
- Watson laboratories
- Zydus pharmaceuticals usa
- Pfizer
- Sandoz
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antithrombotic Drugs Market Size (2021-2032)
- 2.2.2 Global Antithrombotic Drugs Sales (2021-2032)
- 2.2.3 Global Antithrombotic Drugs Market Average Price (2021-2032)
- 2.3 Antithrombotic Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Rivaroxaban
- 2.3.3 Fondaparinux
- 2.3.4 Heparin
- 2.3.5 Apixaban
- 2.3.6 Edoxaban
- 2.3.7 Debigatran
- 2.4 Antithrombotic Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Retailers
- 2.4.3 Hospital Pharmacies
- 2.4.4 Drug Stores
- 2.4.5 General Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antithrombotic Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antithrombotic Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Antithrombotic Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Antithrombotic Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Antithrombotic Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antithrombotic Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antithrombotic Drugs, Product Type & Application
- 3.8 Global Manufacturers of Antithrombotic Drugs, Established Date
- 3.9 Global Antithrombotic Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott laboratories
- 4.1.1 Abbott laboratories Company Information
- 4.1.2 Abbott laboratories Business Overview
- 4.1.3 Abbott laboratories Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott laboratories Antithrombotic Drugs Product Portfolio
- 4.1.5 Abbott laboratories Recent Developments
- 4.2 Bristol myers squibb pharma
- 4.2.1 Bristol myers squibb pharma Company Information
- 4.2.2 Bristol myers squibb pharma Business Overview
- 4.2.3 Bristol myers squibb pharma Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bristol myers squibb pharma Antithrombotic Drugs Product Portfolio
- 4.2.5 Bristol myers squibb pharma Recent Developments
- 4.3 Bristol-Myers Squibb
- 4.3.1 Bristol-Myers Squibb Company Information
- 4.3.2 Bristol-Myers Squibb Business Overview
- 4.3.3 Bristol-Myers Squibb Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bristol-Myers Squibb Antithrombotic Drugs Product Portfolio
- 4.3.5 Bristol-Myers Squibb Recent Developments
- 4.4 Pharmacia
- 4.4.1 Pharmacia Company Information
- 4.4.2 Pharmacia Business Overview
- 4.4.3 Pharmacia Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pharmacia Antithrombotic Drugs Product Portfolio
- 4.4.5 Pharmacia Recent Developments
- 4.5 Pliva
- 4.5.1 Pliva Company Information
- 4.5.2 Pliva Business Overview
- 4.5.3 Pliva Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pliva Antithrombotic Drugs Product Portfolio
- 4.5.5 Pliva Recent Developments
- 4.6 Watson laboratories
- 4.6.1 Watson laboratories Company Information
- 4.6.2 Watson laboratories Business Overview
- 4.6.3 Watson laboratories Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Watson laboratories Antithrombotic Drugs Product Portfolio
- 4.6.5 Watson laboratories Recent Developments
- 4.7 Zydus pharmaceuticals usa
- 4.7.1 Zydus pharmaceuticals usa Company Information
- 4.7.2 Zydus pharmaceuticals usa Business Overview
- 4.7.3 Zydus pharmaceuticals usa Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zydus pharmaceuticals usa Antithrombotic Drugs Product Portfolio
- 4.7.5 Zydus pharmaceuticals usa Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Antithrombotic Drugs Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Sandoz
- 4.9.1 Sandoz Company Information
- 4.9.2 Sandoz Business Overview
- 4.9.3 Sandoz Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sandoz Antithrombotic Drugs Product Portfolio
- 4.9.5 Sandoz Recent Developments
5 Global Antithrombotic Drugs Market Scenario by Region
- 5.1 Global Antithrombotic Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antithrombotic Drugs Sales by Region: 2021-2032
- 5.2.1 Global Antithrombotic Drugs Sales by Region: 2021-2026
- 5.2.2 Global Antithrombotic Drugs Sales by Region: 2027-2032
- 5.3 Global Antithrombotic Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Antithrombotic Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Antithrombotic Drugs Revenue by Region: 2027-2032
- 5.4 North America Antithrombotic Drugs Market Facts & Figures by Country
- 5.4.1 North America Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antithrombotic Drugs Sales by Country (2021-2032)
- 5.4.3 North America Antithrombotic Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Antithrombotic Drugs Market Facts & Figures by Country
- 5.5.1 Europe Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antithrombotic Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Antithrombotic Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Antithrombotic Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antithrombotic Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antithrombotic Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antithrombotic Drugs Market Facts & Figures by Country
- 5.7.1 South America Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antithrombotic Drugs Sales by Country (2021-2032)
- 5.7.3 South America Antithrombotic Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Antithrombotic Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antithrombotic Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antithrombotic Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Antithrombotic Drugs Sales by Type (2021-2032)
- 6.1.1 Global Antithrombotic Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Antithrombotic Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Antithrombotic Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Antithrombotic Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antithrombotic Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Antithrombotic Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antithrombotic Drugs Sales by Application (2021-2032)
- 7.1.1 Global Antithrombotic Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Antithrombotic Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Antithrombotic Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Antithrombotic Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antithrombotic Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Antithrombotic Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antithrombotic Drugs Value Chain Analysis
- 8.1.1 Antithrombotic Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antithrombotic Drugs Production Mode & Process
- 8.2 Antithrombotic Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antithrombotic Drugs Distributors
- 8.2.3 Antithrombotic Drugs Customers
9 Global Antithrombotic Drugs Analyzing Market Dynamics
- 9.1 Antithrombotic Drugs Industry Trends
- 9.2 Antithrombotic Drugs Industry Drivers
- 9.3 Antithrombotic Drugs Industry Opportunities and Challenges
- 9.4 Antithrombotic Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst